News

Cardone Ventures and REVIV Launch Revolutionary Health System

Cardone Ventures and REVIV Launch Revolutionary Health System

Introduction to a New Era of Health

Cardone Ventures, a prominent business growth and investment firm, is making waves with its latest collaboration with REVIV Global, a leader in personalized health solutions. Together, they are launching the world’s first patented 10X Precision Nutrition System, marking a significant expansion into international markets. This initiative sets an innovative standard, shaping how health optimization is approached globally.

Revolutionary Genetic Insights

The 10X Precision Genetic Test stands as a key component of this groundbreaking system. By utilizing advanced technology and artificial intelligence, this test can analyze up to 20 million genetic variations, producing an impressively accurate biological profile of individuals. With results reaching 99.97% precision, this test—developed by esteemed biotechnologist Dr. Daniel Wallerstorfer—ensures that individuals receive insights that are tailor-made for their unique genetic makeup.

A Simple and Efficient Process

Participants in this program will experience a non-invasive testing process. An oral swab sample is collected and sent to a cutting-edge laboratory that employs Micro Array technology, analyzing around 700,000 DNA variations. This information is then enhanced by AI bioinformatics, yielding a detailed report that arrives within six weeks.

Comprehensive Nutritional Insights

The report, which exceeds 400 pages, offers profound insights into nutritional needs, weight management, and additional lifestyle factors. Participants can explore how their genetic profile impacts their:

  • Caffeine absorption and metabolism
  • Inflammatory response and immune function
  • Blood pressure sensitivity to salt
  • Body fat distribution and muscle retention
  • And much more.

Transforming Health with Personalized Solutions

Equipped with their genetic insights, individuals gain access to a suite of personalized health solutions, including:

  • 10X Precision Supplements: These are custom-formulated micro-bead supplements for optimal nutrient absorption, focusing on enhancing digestion, immunity, skin health, energy levels, and metabolic functions.
  • 10X Precision IV Drip Therapy: This service offers IV therapy tailored to an individual’s unique genetic profile, aiming to provide enhanced wellness and recovery. Clients can book their personalized IV treatment through a QR code provided in their report, accessible at any REVIV or 10X Health clinic worldwide.

Expert Commentary

Sarah Lomas, the CEO of REVIV Global, emphasizes the significance of this partnership, stating, "This collaboration eliminates the guesswork associated with health trends by prioritizing science-backed, data-driven solutions tailored to every individual. We are on the precipice of a health revolution, integrating over a decade’s worth of research and three million IV therapies into one coherent system. This will empower individuals to take full control of their health as never before."

A Vision for Global Health

Brandon Dawson, CEO of Cardone Ventures and 10X Health, shares his optimism regarding the launch. He declares, "We aim to redefine the health and wellness landscape by marrying cutting-edge genetic technologies with REVIV's experience in personalized health solutions. This initiative is just the first step of a broader mission to provide precision health solutions on a global scale, paving the way for healthier futures worldwide."

About Cardone Ventures

Cardone Ventures stands at the forefront of business consultancy and investment management. Co-founded by scaling professionals Brandon Dawson and Natalie Dawson, alongside renowned entrepreneur Grant Cardone, the firm specializes in facilitating the exponential growth of small to medium enterprises. With a strong focus on empowering business owners through innovative strategies, they offer a diverse range of services including consulting, workshops, and investments designed to yield significant results.

About REVIV Global

REVIV Global Ltd excels in the wellness sphere, particularly in IV therapy and vitamin supplementation. With a commitment to enhancing vitality and preventing health decline, REVIV leads the market in personalized healthcare strategies tailored to the needs of modern life. Their range of IV therapies and vitamin boosters focuses on maximizing hydration, wellness, and energy levels for individuals looking to restore their health status.

Frequently Asked Questions

What is the 10X Precision Nutrition System?

The 10X Precision Nutrition System is an innovative health solution that uses genetic insights to provide personalized nutrition and wellness recommendations.

How does the genetic testing process work?

A simple oral swab sample is collected and analyzed using advanced technology to identify up to 20 million genetic variations.

What benefits do participants receive from the program?

Participants gain access to tailored supplements, personalized IV therapy, and detailed health reports that optimize their wellness journey.

Who developed the 10X Precision Genetic Test?

The test was developed by Dr. Daniel Wallerstorfer, an expert in biotechnology, ensuring high accuracy and reliable insights.

What is Cardone Ventures' mission?

Cardone Ventures aims to empower businesses for exponential growth while providing innovative solutions tailored to the unique needs of each client.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 252

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 379

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 472

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 401

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 391

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 65

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 250

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 432

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 296

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading

Top 5 Most Recently Viewed Articles

Long-Term Recovery Efforts Post-Hurricane Helene Announced

Updated Category News Views 54

Long-Term Recovery Efforts Post-Hurricane Helene Announced As communities continue to grapple with the aftermath of Hurricane Helene, U.S. Homeland Security Secretary Alejandro Mayorkas has conveyed that the path to recovery will be both arduous and lengthy. According to Mayorkas, the process of rebuilding will not only be time-consuming but will also incur significant...

Continue Reading
Lloyds Energy Evaluates LNG Opportunities in Asia, Africa

Updated Category News Views 1

Big Moves in LNG: Lloyds Energy Sets Sights on Emerging Markets Well, folks, Lloyds Energy is stepping into the spotlight with their eye on Liquefied Natural Gas—trying to figure out if this is the golden ticket or just another case of corporate daydreaming. They're peering into high-growth energy markets worldwide, poking around to see where they can wedge into the LNG...

Continue Reading
CITGO Introduces Premier Status for Enhanced Customer Savings

Updated Category News Views 208

CITGO Unveils Premier Status Loyalty Program CITGO Petroleum Corporation is taking its Club CITGO loyalty program to new heights with the launch of Premier Status, a tier dedicated to rewarding loyal fuel customers even further. This new offering allows these valued members to enjoy significant benefits, including a heightened reward of an additional 3¢ per gallon, which...

Continue Reading
SWOOP Analytics Appoints Edward Rhemrev as European Director

Updated Category News Views 230

SWOOP Analytics Expands Its European Leadership Team In a noteworthy development for the digital workplace analytics field, SWOOP Analytics has named Edward Rhemrev as their new Director of Customer Success and Growth in Europe. This strategic appointment signals the company's dedication to enhancing its impact and support for internal communications. Edward Rhemrev's...

Continue Reading
Exploring Growth Dynamics in Today's Tech Venture Landscape

Updated Category News Views 171

Understanding the Current Landscape of Tech Ventures As the economy evolves, the dynamics of venture capital and the startup ecosystem undergo significant transformations. HSBC Innovation Banking has recently shared a comprehensive overview of the factors driving growth in the U.S. technology sector. The report delves into notable trends affecting startup development, the...

Continue Reading